Filing Details
- Accession Number:
- 0000899243-20-019186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 17:11:41
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-15 17:11:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1629137 | Global Blood Therapeutics Inc. | GBT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1405253 | S Jeffrey Farrow | C/O Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-07-13 | 15,208 | $75.00 | 3,048 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2020.